Showing results (731-740 of 5,684) with videos related to
Sort By:
Pageof 569
The Oncologist|June 27, 2025
Correlation of TROP2 expression with clinico-pathological features and outcomes in HR+/HER2- breast cancer receiving neoadjuvant chemotherapyHagar Elghazawy, Mahmoud Elghazawy, Hamdy A Azim, et al.The Oncologist|June 28, 2025
The predictive value of serial troponin measurements in patients treated with immune checkpoint inhibitorsMoran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin, et al.The Oncologist|July 4, 2025
Improving genetics equity: identifying women eligible for genetic care services using mammography clinics in underserved areas as screening hubsDarya Kizub, Rachel Bluebond, Sierra Green, et al.The Oncologist|July 10, 2025
Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case seriesIan Nykaza, Andrea Moy, Stephen W Dusza, et al.The Oncologist|July 10, 2025
Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain mutation (A641R) that responds to selpercatinibNaoki Fukuda, Kazuhisa Toda, Tomohiro Chiba, et al.The Oncologist|July 16, 2025
Real-world outcomes of first-line treatment with HLX02 versus reference trastuzumab plus pertuzumab in HER2-positive metastatic breast cancerYing Yan, Ruyan Zhang, Yanling Li, et al.The Oncologist|July 24, 2025
Risk factors of immune checkpoint inhibitor-related cardiotoxicity: a scoping reviewYixuan Wang, Liyan Zhang, Zhenzhen Su, et al.The Oncologist|July 23, 2025
ALK-positive adult histiocytosis with a TFG-ALKfusion geneJi Yun Lee, Ki Rim Lee, Sei Na, et al.The Oncologist|July 17, 2025
Conservative lymph node surgery for patients with stage iii melanoma: a prospective longitudinal cohortDavid Moreno-Ramírez, Almudena Fernández-Orland, Blanca de-Unamuno, et al.The Oncologist|July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN studyAndrew J Wagner, William D Tap, Sebastian Bauer, et al.Pageof 569